Relationship of Serum Irisin Levels, Physical Activity, and Metabolic Syndrome Biomarkers in Obese Individuals with Low-calorie Intake and Non-obese Individuals with High-calorie Intake

Overview

Journal J Health Popul Nutr

Publisher Biomed Central

Specialties Nutritional Sciences
Public Health

Date 2025 Jan 3

PMID 39748434

Authors

Jalal Hejazi

Bijan Ghobadian

Nasrin Ghasemi

Hossein Sadeh

Nasim Abedimanesh

Mehran Rahimlou

Affiliations

Soon will be listed here.

Abstract

Background: Despite all the advances in our knowledge regarding obesity, our understanding of its etiology is still far from complete. This study aimed to evaluate the association of serum irisin levels with physical activity and some of the metabolic syndrome-related biomarkers among obese people with low-calorie intake and non-obese people with high-calorie intake.

Methods: Obese and non-obese healthy individuals with respectively low and high-calorie intakes were recruited. Irisin and other biomarkers were measured using standard biochemical methods. Participants' physical activity was evaluated by administering the International Physical Activity Questionnaire (IPAQ). To analyze the body composition of the participants, a standard body composition device (ioi 353) was applied. Logistic regression was used to calculate the odds ratio (OR) and to examine the effect of confounders such as age, sex, genetics, and activity.

Results: Data from the seventy-seven participants were included in the final analysis. The mean age of the participants in the obese and non-obese groups was 38.33 ± 14.88 and 30.24 ± 13.37 years, respectively. Participants in the obese group had lower physical activity compared to the non-obese group (3395.38 ± 2801 MET-min/week vs. 6015.18 ± 3178 MET-min/week; p < 0.001). The Irisin concentration in the obese and non-obese groups was 7.84 ± 2.49 ng/ml and 8.06 ± 1.89 ng/ml, respectively, which wasn't significantly different (p = 0.66). We observed a noteworthy and favorable association between irisin concentration and total body water (TBW), lean body mass (LBM), and soft lean mass (SLM) in the non-obese group.

Conclusions: These data indicated that although obese participants were relatively inactive compared to non-obese individuals, circulating irisin level wasn't significantly different between the two groups.

References

Sanchis-Gomar F, Alis R, Pareja-Galeano H, Sola E, Victor V, Rocha M . Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients. Endocrine. 2014; 46(3):674-7. DOI: 10.1007/s12020-014-0170-9. View

Wozniak S, Gee L, Wachtel M, Frezza E . Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci. 2008; 54(9):1847-56. DOI: 10.1007/s10620-008-0585-3. View

Yamaoka K, Tango T . Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med. 2012; 10:138. PMC: 3523078. DOI: 10.1186/1741-7015-10-138. View

Butt Z, Hackett J, Volkoff H . Irisin in goldfish (Carassius auratus): Effects of irisin injections on feeding behavior and expression of appetite regulators, uncoupling proteins and lipoprotein lipase, and fasting-induced changes in FNDC5 expression. Peptides. 2017; 90:27-36. DOI: 10.1016/j.peptides.2017.02.003. View

Sesti G, Andreozzi F, Fiorentino T, Mannino G, Sciacqua A, Marini M . High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol. 2014; 51(5):705-13. DOI: 10.1007/s00592-014-0576-0. View

Binay C, Paketci C, Guzel S, Samanci N . Serum Irisin and Oxytocin Levels as Predictors of Metabolic Parameters in Obese Children. J Clin Res Pediatr Endocrinol. 2017; 9(2):124-131. PMC: 5463284. DOI: 10.4274/jcrpe.3963. View

Bakhtiary M, Morvaridzadeh M, Agah S, Rahimlou M, Christopher E, Zadro J . Effect of Probiotic, Prebiotic, and Synbiotic Supplementation on Cardiometabolic and Oxidative Stress Parameters in Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis. Clin Ther. 2021; 43(3):e71-e96. DOI: 10.1016/j.clinthera.2020.12.021. View

Sahin-Efe A, Upadhyay J, Ko B, Dincer F, Park K, Migdal A . Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study. Metabolism. 2017; 79:24-32. DOI: 10.1016/j.metabol.2017.10.011. View

Wan Q, Qian Y, Xia M, Tan L, Lv X, Meng X . Young obese patients may benefit from GnRH-a long protocol contributing to higher implantation rate and live birth rate of fresh IVF-ET cycles. Heliyon. 2023; 9(10):e20016. PMC: 10556590. DOI: 10.1016/j.heliyon.2023.e20016. View

10.

Yang Y, Chen Z, Yang X, Deng R, Shi L, Yao L . Piperazine ferulate prevents high-glucose-induced filtration barrier injury of glomerular endothelial cells. Exp Ther Med. 2021; 22(4):1175. PMC: 8393711. DOI: 10.3892/etm.2021.10607. View

11.

Guo W, Zhang Z, Li L, Liang X, Wu Y, Wang X . Gut microbiota induces DNA methylation via SCFAs predisposing obesity-prone individuals to diabetes. Pharmacol Res. 2022; 182:106355. DOI: 10.1016/j.phrs.2022.106355. View

12.

Shoukry A, Shalaby S, El-Arabi Bdeer S, Mahmoud A, Mousa M, Khalifa A . Circulating serum irisin levels in obesity and type 2 diabetes mellitus. IUBMB Life. 2016; 68(7):544-56. DOI: 10.1002/iub.1511. View

13.

Bostrom P, Wu J, Jedrychowski M, Korde A, Ye L, Lo J . A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481(7382):463-8. PMC: 3522098. DOI: 10.1038/nature10777. View

14.

Vaughan R, Gannon N, Barberena M, Garcia-Smith R, Bisoffi M, Mermier C . Characterization of the metabolic effects of irisin on skeletal muscle in vitro. Diabetes Obes Metab. 2014; 16(8):711-8. DOI: 10.1111/dom.12268. View

15.

Staiger H, Bohm A, Scheler M, Berti L, Machann J, Schick F . Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS One. 2013; 8(4):e61903. PMC: 3636229. DOI: 10.1371/journal.pone.0061903. View

16.

Mifflin M, St Jeor S, Hill L, Scott B, Daugherty S, Koh Y . A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990; 51(2):241-7. DOI: 10.1093/ajcn/51.2.241. View

17.

Amirkalali B, Hosseini S, Heshmat R, Larijani B . Comparison of Harris Benedict and Mifflin-ST Jeor equations with indirect calorimetry in evaluating resting energy expenditure. Indian J Med Sci. 2008; 62(7):283-90. View

18.

Park K, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung K . Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013; 98(12):4899-907. PMC: 3849667. DOI: 10.1210/jc.2013-2373. View

19.

Yang Z, Chen X, Chen Y, Zhao Q . Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice. Int J Clin Exp Pathol. 2015; 8(6):6490-7. PMC: 4525860. View

20.

Tibana R, da Cunha Nascimento D, Frade de Souza N, de Souza V, de Sousa Neto I, Voltarelli F . Irisin Levels Are not Associated to Resistance Training-Induced Alterations in Body Mass Composition in Older Untrained Women with and without Obesity. J Nutr Health Aging. 2017; 21(3):241-246. DOI: 10.1007/s12603-016-0748-4. View